Westdijk et al., 2011 - Google Patents
Characterization and standardization of Sabin based inactivated polio vaccine: proposal for a new antigen unit for inactivated polio vaccinesWestdijk et al., 2011
View PDF- Document ID
- 2605700122344100919
- Author
- Westdijk J
- Brugmans D
- Martin J
- van’t Oever A
- Bakker W
- Levels L
- Kersten G
- Publication year
- Publication venue
- Vaccine
External Links
Snippet
GMP-batches of Sabin-IPV were characterized for their antigenic and immunogenic properties. Antigenic fingerprints of Sabin-IPV reveal that the D-antigen unit is not a fixed amount of antigen but depends on antibody and assay type. Instead of the D-antigen unit we …
- 229960005486 vaccines 0 title abstract description 70
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses positive-sense
- C12N2770/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses positive-sense ssRNA Viruses positive-sense
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Westdijk et al. | Characterization and standardization of Sabin based inactivated polio vaccine: proposal for a new antigen unit for inactivated polio vaccines | |
Chong et al. | Production of EV71 vaccine candidates | |
Liu et al. | Identification and characterization of a cross-neutralization epitope of Enterovirus 71 | |
Mackay et al. | A solid-phase competition ELISA for measuring antibody to foot-and-mouth disease virus | |
Verch et al. | Principles of vaccine potency assays | |
Ferguson et al. | Antigenic structure of poliovirus in inactivated vaccines | |
White et al. | Defining levels of dengue virus serotype-specific neutralizing antibodies induced by a live attenuated tetravalent dengue vaccine (TAK-003) | |
Wei et al. | Bacteria expressed hepatitis E virus capsid proteins maintain virion-like epitopes | |
Harmsen et al. | Effect of thiomersal on dissociation of intact (146S) foot-and-mouth disease virions into 12S particles as assessed by novel ELISAs specific for either 146S or 12S particles | |
Kersten et al. | Antigenic and immunogenic properties of inactivated polio vaccine made from Sabin strains | |
Chou et al. | Immunological evaluation and comparison of different EV71 vaccine candidates | |
Tano et al. | Antigenic characterization of a formalin-inactivated poliovirus vaccine derived from live-attenuated Sabin strains | |
Uusi-Kerttula et al. | Comparison of human saliva and synthetic histo-blood group antigens usage as ligands in norovirus-like particle binding and blocking assays | |
Hankaniemi et al. | A comparative study of the effect of UV and formalin inactivation on the stability and immunogenicity of a Coxsackievirus B1 vaccine | |
CN102323428A (en) | Riemerella anatipestifer antibody indirect ELISA method detection kit and application thereof | |
Simizu et al. | Development of inactivated poliovirus vaccine derived from Sabin strains | |
Lei et al. | WHO working group meeting to develop WHO Recommendations to assure the quality, safety and efficacy of enterovirus 71 vaccines | |
CN104569428B (en) | A kind of enterovirns type 71 killed vaccine antigen enzyme-linked immunologic detecting kit | |
Wang et al. | A neutralizing monoclonal antibody-based competitive ELISA for classical swine fever C-strain post–vaccination monitoring | |
Kouiavskaia et al. | Universal ELISA for quantification of D-antigen in inactivated poliovirus vaccines | |
Yang et al. | Generation of monoclonal antibodies against foot‐and‐mouth disease virus SAT 2 and the development of a lateral flow strip test for virus detection | |
Rosenfeld et al. | Cross-reactive antibody responses against nonpoliovirus enteroviruses | |
Shiota et al. | Development and evaluation of a rapid neutralizing antibody test for rabies | |
Rezapkin et al. | Improved ELISA test for determination of potency of inactivated poliovirus vaccine (IPV) | |
Vander Veen et al. | Rapid development of an efficacious swine vaccine for novel H1N1 |